Lin Kong

Center for High Pressure Science & Technology Advanced Research, Shanghai Genon Biological Products (China)

Papers

Total Citations

H-Index

About

Lin Kong is a leading figure in particle therapy, with a research focus on advanced treatment delivery systems and clinical guidelines for ion beam radiotherapy. Her most impactful work centers on the development and evaluation of a six-degree-of-freedom treatment chair (6DTC) designed for patient positioning in an upright posture at fixed horizontal beam lines. This innovation, detailed in her 2020 paper (34 citations), addresses a critical challenge in proton and carbon ion therapy by enabling precise, robust alignment under x-ray image guidance, thereby expanding treatment accessibility and accuracy. Kong also contributed to the "Ion therapy guideline (Version 2020)" (4 citations), which synthesizes decades of charged particle radiotherapy history—from Lawrence Berkeley’s 1954 proton therapy to Japan’s National Institute of Radiological Sciences’ pioneering work—into a practical framework for modern clinical practice. Her work bridges engineering and clinical oncology, offering tangible solutions for fixed-beam facilities while shaping international standards. With a career dedicated to advancing particle therapy, Kong’s contributions are essential for researchers and clinicians striving to improve patient outcomes through innovative positioning technologies and evidence-based protocols.